Emmy Bell is a Nephrology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 11 publications with 381 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1717 6th Ave S
Birmingham, AL 352331801
Telephone
800-822-8816Registry record last updated 28 Jun 2023.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- AKEBIA THERAPEUTICS INCProgram year20251 payment
- Fresenius USA Marketing, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.8%Calcium channel blocker19.8%Amlodipine Besylate100%Part D≥17 patientsAngiotensin receptor blocker (ARB)15.6%Losartan Potassium100%Part D≥12 patients+ 4 more classes in this area
Other
15.6%Phosphate Binder9%Sevelamer Carbonate100%Part D<11 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia6.6%Lokelma100%Part D<11 patientsMetabolism & gastrointestinal
5.7%SGLT2 inhibitor5.7%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1989–1995 per NIH RePORTER. The latest:
- EFFECT OF CAPTOPRIL ON HYDRO-OSMOTIC ACTION OF VASOPRESSIN
University of Alabama at Birmingham
FY1995M01RR000032 - EFFECT OF CAPTOPRIL ON HYDRO-OSMOTIC ACTION OF VASOPRESSIN
University of Alabama at Birmingham
FY1993M01RR000032 - EFFECT OF CAPTOPRIL ON HYDRO-OSMOTIC ACTION OF VASOPRESSIN
University of Alabama at Birmingham
FY1992M01RR000032
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Rare Case of Severe Myositis with Microsporidia Invasion of the Kidneys
Journal of the American Society of Nephrology
2024 - Updated Pathway to Micro-elimination of Hepatitis C Virus in the Hemodialysis Population
Kidney International Reports
2021 - Incident ESRD and Treatment-Resistant Hypertension: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
American Journal of Kidney Diseases
2014 - Prevalence of Apparent Treatment-Resistant Hypertension among Individuals with CKD
Clinical Journal of the American Society of Nephrology
2013 - Contribution of Food Additives to Sodium and Phosphorus Content of Diets Rich in Processed Foods
Journal of Renal Nutrition
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Vera Bittner
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Erik Roberson
University of Alabama at Birmingham
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”